Questo è quello che abbiamo trovato per te
People with moderate to severe obstructive sleep apnea who received tirzepatide, marketed as Zepbound, for 52 weeks cut the number of times per night that they stopped breathing or weren’t getting enough oxygen by about half compared with those who received a placebo, according to a pair of randomized clinical trials involving 469 total participants with obesity.
Studio identifica i pazienti a rischio di chirurgia inefficace
Autore/Fonte: University of California San Diego
PoliMi, l’IA rivoluzionerà medicina personalizzata entro 5 anni
In two randomized trials, this drug improved polysomnographic and clinical outcomes.
Autore/Fonte: University of California San Diego School of Medicine
New England Journal of Medicine, Ahead of Print.
New England Journal of Medicine, Ahead of Print.
Immunoterapia più chemioterapia raddoppia il tasso a lungo termine
Immunoterapia più chemioterapia raddoppia il tasso a lungo termine
Permetterà di fermare progressione con singola somministrazione
